Performance reporting through clear and timely information
Enabling better health care while creating a sustained and growing investment opportunity.
If you invest or are considering investing in TSO3, you will want to keep current with the Company’s performance and understand any fluctuations. TSO3’s online Investor Relations section keeps you up-to-date with the latest in financial reporting, including annual reports, quarterly results, and conference call webcasts. As an investment, TSO3 builds value in the health care market through rapid research prototyping. A leading innovator in low-temperature sterilization technology, TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.
|Investor News||Investor Events|
|October 03, 2017: TSO3 Duodenoscope Sterilization Technology to be Featured at the 18th World Federation for Hospital Sterilisation Sciences (WFHSS) Congress in Bonn, Germany||August 02, 2017: TSO3 Reports Record Second Quarter 2017 Results|
|September 27, 2017: TSO3 Provides an Update on Regulatory Activity|
|September 25, 2017: TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer|